Buyback Approval At Rs. 670 Per Share Pushes Novartis Scrip Down By 9%

Subscribe to GoodReturns
For Quick Alerts
Subscribe Now  
For Quick Alerts
For Daily Alerts

    The board of Novartis has approved a share buyback plan for Novartis and a lower price band of Rs. 670 per share decided for the buyback has drifted the stock southwards on price.

    Buyback Approval At Rs. 670 Per Share Pushes Novartis Scrip Down By 9%

    After slipping to Rs. 626 in noon hours on the BSE, the stock was last seen trading at Rs. 636. The buyback price is 2% lower than the Friday's closing price of the stock which was Rs. 683 and it shall comprise a buyback of as many as 3.45 million equity shares of the company which represents close to 12% of the total paid up equity base of the company.

    In the quarter ended June for the FY2017-18, the company's equity holding was largely with promoters of the company while the remaining rested with the public.
    As against the benchmark Sensex, the stock has performed substantially good and saw a surge of almost 17% in one month's time.

    Read more about: novartis buyback equity shares
    Story first published: Monday, September 25, 2017, 15:45 [IST]
    Company Search
    Enter the first few characters of the company's name or the NSE symbol or BSE code and click 'Go'

    Find IFSC

    We use cookies to ensure that we give you the best experience on our website. This includes cookies from third party social media websites and ad networks. Such third party cookies may track your use on Goodreturns sites for better rendering. Our partners use cookies to ensure we show you advertising that is relevant to you. If you continue without changing your settings, we'll assume that you are happy to receive all cookies on Goodreturns website. However, you can change your cookie settings at any time. Learn more